MedPath

Amphotericin B

Generic Name
Amphotericin B
Brand Names
Abelcet, Ambisome, Amphotec, Fungizone
Drug Type
Small Molecule
Chemical Formula
C47H73NO17
CAS Number
1397-89-3
Unique Ingredient Identifier
7XU7A7DROE

Overview

Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

Background

Amphotericin B shows a high order of in vitro activity against many species of fungi. Histoplasma capsulatum, Coccidioides immitis, Candida species, Blastomyces dermatitidis, Rhodotorula, Cryptococcus neoformans, Sporothrix schenckii, Mucor mucedo, and Aspergillus fumigatus are all inhibited by concentrations of amphotericin B ranging from 0.03 to 1.0 mcg/mL in vitro. While Candida albicans is generally quite susceptible to amphotericin B, non-albicans species may be less susceptible. Pseudallescheria boydii and Fusarium sp. are often resistant to amphotericin B. The antibiotic is without effect on bacteria, rickettsiae, and viruses.

Indication

Used to treat potentially life threatening fungal infections.

Associated Conditions

  • Coccidioidomycosis
  • Fungal Infections
  • Histoplasmosis
  • Invasive Aspergillosis
  • Invasive Fungal Infections
  • Leishmaniasis
  • Meningitis, Cryptococcal
  • Meningitis, Fungal
  • Mucocutaneous Leishmaniasis
  • Mycotic endophthalmitis
  • Penicillium marneffei infection
  • Visceral Leishmaniasis
  • Candidal cystitis
  • Disseminated Cryptococcosis
  • Fungal osteoarticular infections
  • Ocular aspergillosis
  • Refractory aspergillosis
  • Severe Coccidioidomycosis
  • Severe Cryptococcosis
  • Severe Fungal infection caused by Basidiobolus spp.
  • Severe Fungal infection caused by Conidiobolus spp.
  • Severe Fungal infection caused by sporotrichosis spp.
  • Severe Histoplasmosis
  • Severe Mucocutaneous leishmaniasis
  • Severe North American blastomycosis
  • Severe Systemic candidiasis

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath